Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of Relugolix and intermediate compounds

A compound, a technology of hydrazine hydrate, applied in the field of preparation of Relugolix, can solve problems such as being unsuitable for practical production and application, difficult to remove, etc., and achieve the effects of good industrial application prospect, less impurities and mild reaction conditions

Inactive Publication Date: 2021-05-04
SHANGHAI DUDE MEDICAL SCI & TECH CO LTD
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the fatal problem of this method is that ring-opening impurities and demethylation impurities are generated during the reduction step, and these two impurities can further react to derive new impurities, which remain in the final target product and are difficult to remove
Not suitable for practical production application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of Relugolix and intermediate compounds
  • Preparation method of Relugolix and intermediate compounds
  • Preparation method of Relugolix and intermediate compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1: the preparation of compound 3-a

[0042]

[0043] Compound 2-a (25.0 g) was put into methanol (200.0 ml), 10% Pd / C (2.5 g) and ammonium formate (4.77 g) were added thereto, and stirred at 50±5° C. for 4 hours. After the reaction was completed, the mother liquor was collected by filtration, and the filter cake was washed with methanol. Raise the mother liquor to 40±5°C and stir for 1 hour, then cool down to 5±5°C, collect crystals by filtration, and wash the filter cake with cold methanol. Drying under reduced pressure gave compound 3-a (22.0 g). yield: 92%, HPLC purity 99.64%.

[0044] 1 H NMR (400MHz, Chloroform-d) δ14.06(d, J=27.0Hz, 1H), 8.56(d, J=9.6Hz, 1H), 7.66(s, 1H), 7.54(d, J=8.1Hz ,2H),7.24(d,J=8.1Hz,2H),7.16–7.07(m,1H),6.98(d,J=9.5Hz,1H),6.73(t,J=7.7Hz,2H),5.03 (s,2H),4.23(s,1H),4.10(s,4H),3.82(s,3H),3.49(s,2H),2.19(s,6H),1.77(s,1H),1.64( s,2H),1.01(s,1H),0.79(t,J=7.1Hz,2H).

Embodiment 2

[0045] Embodiment 2: the preparation of compound 4-a

[0046]

[0047] Compound 3-a (10.0g) and 1,1'-carbonyldiimidazole (5.31g) were put into dichloromethane (40.0ml), and N,N-diisopropylethylamine (4.24g ), and stirred at 20±5° C. for 1-2 hours (hereinafter referred to as reaction mixture A).

[0048]Methoxylamine hydrochloride (13.6eq) was put into dichloromethane (60.0ml), and N,N-diisopropylethylamine (21.18g) was added to the mixture, and stirred at 25±5°C for 1 hour (hereinafter referred to as reaction mixture B). Reaction mixture B was slowly added to reaction mixture A at 0±5°C, and stirred at the same temperature for 1-2 hours. At 0±5°C, add saturated sodium bicarbonate solution to the reaction mixture, stir for 30 minutes and let it stand, and separate the organic phase, wash with saturated sodium bicarbonate solution, distill off the organic solvent under reduced pressure, and wash the residue with ethyl acetate Recrystallized from isopropyl ether to obtain c...

Embodiment 3

[0050] Embodiment 3: preparation compound 1

[0051]

[0052] Compound 4-a (5.0 g) was added to methanol (50.0 ml), sodium methoxide (0.59 g) was added to the mixture, and stirred at room temperature for 2-3 hours. Cool to 0°C or lower and stir for 2-4 hours, collect crystals by filtration, wash the filter cake with methanol and dry under reduced pressure at 50-60°C. The obtained solid was put into tetrahydrofuran, the temperature of the mixture was raised to 60±5°C, and stirred at the same temperature for 1 hour, the mixture was cooled to 0°C, and aged with stirring at the same temperature for 2 hours. The crystals were collected by filtration, and the filter cake was washed with tetrahydrofuran. The filter cake was recrystallized from dimethyl sulfoxide (DMSO) and ethanol to obtain compound 1 (4.25 g). Yield: 93%, HPLC purity 99.68%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a novel preparation method of Relugolix and two novel intermediate compounds. The preparation method comprises the following steps: reducing an existing compound 2 to obtain an amino compound 3, then, carrying out a condensation reaction on the compound 3 and methoxyamine or a salt thereof to obtain a compound 4, and finally, carrying out a cyclization reaction on the compound 4 to obtain a target compound 1. The preparation method is mild in reaction condition and high in reaction controllability; and the method has the advantages of few impurities, no ring-opening and demethylation impurities, good purity, simple post-treatment, high yield, environmental protection, economy and good industrial application prospect.

Description

technical field [0001] The invention relates to the technical field of preparation methods of Relugolix. Background technique [0002] Relugolix is ​​a gonadotropin-releasing hormone (GnRH) antagonist. The secretion of anterior pituitary hormones is feedback-controlled by peripheral hormones secreted from the target organs of the corresponding hormones and by secretory-regulating hormones from the hypothalamus. It has been confirmed as hypothalamic hormones, including thyrotropin-releasing hormone (TRH) and gonadotropin-releasing hormone (GnRH). These secretory-regulating hormones from the hypothalamus express their action through receptors thought to be present in the anterior pituitary. Therefore, GnRH antagonists are expected to prevent or treat anterior pituitary hormone-dependent diseases. [0003] According to the literature search, the current domestic and foreign reports on the preparation method of Relugolix include literature 1, and the methods described in pate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D409/12
CPCC07D409/12
Inventor 袁哲东杨瀚杨欣刘新孔锐魏艳
Owner SHANGHAI DUDE MEDICAL SCI & TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com